Joseph H. Antin, MD

Dana-Farber Cancer Institute

Academic Titles

Professor, Medicine, Harvard Medical School

Research Program Affiliation

Member, Lymphoma and Myeloma

Member, Leukemia

Research Abstract

My principle research interests are in the prevention and therapy of graft-versus-host disease (GVHD) and in the use of graft-versus-leukemia to eradicate blood disorders. We have a series of clinical trials available to evaluate several different strategies to prevent GVHD, such as T cell depletion and the use of novel immunosuppressive agents. In addition, we are committed to graft engineering and vaccine development to enhance the ability of transplantation to control blood diseases.